Evolus
EOLS
118 hedge funds and large institutions have $266M invested in Evolus in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 41 reducing their positions, and 13 closing their positions.
493% more call options, than puts
Call options by funds: $4.14M | Put options by funds: $698K
108% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 13
100% more capital invested
Capital invested by funds: $133M → $266M (+$133M)
13% more funds holding
Funds holding: 104 → 118 (+14)
6.01% more ownership
Funds ownership: 37.02% → 43.04% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
29% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 41
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$10.5M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$9.39M |
| 3 |
First Manhattan
New York
|
+$6.39M |
| 4 |
Millennium Management
New York
|
+$3.24M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$3.17M |
Top Sellers
EOLS Hedge Fund Activity: Q1 2022 in Review
118 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q1 2022, worth a combined $266M — up 100% from $133M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new EOLS positions and 13 closed out — a net gain of 14 holders — while 29 added to existing stakes and 41 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $10.5M. The largest seller was Stonepine Capital Management, cutting an estimated $10.9M.
- 118 institutional investors held Evolus (EOLS) as of Q1 2022, up from 104 in Q4 2021.
- Funds reported $266M of Evolus stock for Q1 2022, up 100% quarter-over-quarter.
- 27 funds opened new Evolus positions in Q1 2022 and 13 closed out, a net change of +14 holders.
- The largest Evolus buyer in Q1 2022 was Deerfield Management, an estimated $10.5M added.
- The largest Evolus seller in Q1 2022 was Stonepine Capital Management, an estimated $10.9M sold.
Based on aggregated 13F filings for Q1 2022.